RxDoctor Payments Data

Duong Huynh

Physician Assistant · Springfield, MANPI 1053080093

Payments from drug & device makers

$1,548in general payments, 2019–2025

Across 67 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$704
  • Coloplast$187
  • Antares Pharma, Inc.$152
  • Urogen Pharma, Inc.$88
  • Procept Biorobotics Corporation$81
  • Halozyme Inc$71
  • plus $265 from 7 others

What the payments were for

  • Food & beverage$1,548100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,548 in reported general payments places this provider in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$57,875
Medicare patients
405
Services billed
1,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron133$135,785
MyrbetriqMirabegron98$85,382
Tamsulosin Hcl894$17,537
Methenamine Hippurate96$8,990
Finasteride382$7,631
Oxybutynin Chloride ErOxybutynin Chloride227$7,550
Alfuzosin Hcl ErAlfuzosin Hcl163$3,857
Tolterodine Tartrate ErTolterodine Tartrate37$3,711
Solifenacin Succinate38$3,558
Fosfomycin Tromethamine26$2,920
Testosterone18$2,794
Trospium Chloride38$2,717
Tadalafil14$1,313
Trimethoprim16$968
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst62$668

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$704$135,785133 claims
Astellas Pharma US IncMyrbetriq$61$85,38298 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →